ArticleDiabetes technology & therapeutics2026
Glucose360: An Open-Source Python Platform with Event-Based Integration for Continuous Glucose Monitoring Data Analysis.
Article in Diabetes technology & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
BACKGROUND AND
aimsContinuous glucose monitoring (CGM) devices provide real-time actionable data on blood glucose levels, making them essential tools for effective glucose management. Integrating blood glucose data with food log data is crucial for understanding how dietary choices impact glucose levels. Despite their utility, many CGM applications lack integration with other external services, such as food trackers, and do not generate useful glycemic variability (GV) metrics or advanced visualizations. Existing solutions vary in functionality: some are proprietary, many require additional user programming or custom preprocessing to meet diverse research needs, and few have created solutions to connect CGM data with external services. Recent reviews highlight gaps such as insufficient postprandial analytics, absence of composite indices, and inadequate tools for nontechnical users.
methodsGlucose360 and commonly used alternative CGM applications and tools were compared by calculating GV metrics on 60 participant datasets and by contrasting their general applications for research workflows.
resultsTo address limitations, we developed Glucose360, featuring (1) an open-source python framework for event-based CGM data integration and analysis; (2) automated calculation of glucose metrics specific for meals and exercise events and other short-interval events; and (3) a user-friendly web application, designed for users with minimal programming experience and accessible at vurhd2.shinyapps.io/glucose360/. DISCUSSION: Overall, Glucose360 provides a holistic analysis pipeline that is useful for both individuals and researchers to track and analyze CGM data. The source code for Glucose360 can be found at github.com/vurhd2/Glucose360.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.